Summary: Tissue-specific expression of cre recombinase is a well-established genetic tool to analyze gene function, and it is limited only by the efficiency and specificity of available cre mouse strains. Here, we report the generation of a transgenic line containing a cre cassette with codon usage optimized for mammalian cells (iCre) under the control of a mouse glycoprotein hormone a-subunit (aGSU) regulatory sequences in a bacterial artificial chromosome genomic clone. Initial analysis of this transgenic line, Tg(aGSU-iCre), with cre reporter strains reveals onset of cre activity in the differentiating cells of the developing anterior pituitary gland at embryonic day 12.5, with a pattern characteristic of endogenous aGSU. In adult mice, aGSU-iCre was active in the anterior lobe of the pituitary gland and in the cells that produce aGSU (gonadotropes and thyrotropes) with high penetrance. Little or no activity was observed in other tissues, including skeletal and cardiac muscle, brain, kidney, lungs, testis, ovary, and liver. This aGSU-iCre line is suitable for efficient, specific, and developmentally regulated deletion of floxed alleles in anterior pituitary gonadotropes and thyrotropes. genesis 51:785-792. V C 2013 Wiley Periodicals, Inc.
INTRODUCTION
During the development of the mammalian anterior pituitary gland, the distinct hormone-producing cell types emerge and organize into networks (Budry et al., 2011; Davis et al., 2011) . Initially, precursor cells proliferate and differentiate into five different endocrine cell types that are typified by the hormones that they produce: corticotropes produce adrenocorticotropin (ACTH), thyrotropes produce thyroid stimulating hormone (TSH), somatotropes produce growth hormone (GH), lactotropes produce prolactin (PRL), and gonadotropes produce luteinizing hormone (LH) and folliclestimulating hormone (FSH) . In mouse embryonic development, hormone producing cell types become detectable over a period spanning embryonic days 12.5 (e12.5) to e17.5 (Japon et al., 1994) . Genetic and biochemical studies have identified several of the transcription factors that are crucial for cell lineage determination and differentiation and cell-specific hormonal gene expression (Marcil A et al., 2003) [rev in (Zhu and Rosenfeld, 2004) ]. Both gonadotropes and thyrotropes express a common a-glycoprotein subunit (aGSU), which heterodimerizes with separate bsubunits of the glycoprotein hormones, LH, FSH, and TSH, to give the biologically active hormones. aGSU is the first pituitary hormone component detected during development. The earliest detectable signal is present at e11.5 in the rostral and ventral most region of Rathke's pouch (Burrows et al., 1996) . Deletion of this gene, officially known as chorionic gonadotropin alpha or Cga, revealed that it is necessary after birth for stimulation of thyroid and gonadal growth and function (Kendall et al., 1991) .
The cre-loxP system has become a powerful tool to study the effects of gene deletion in a particular cell type or tissue, especially when conventional gene targeting by homologous recombination in embryonic stem cells results in an early lethal phenotype. To study the pituitary specific effects of gene deletion, we previously generated transgenic mice that express the cre recombinase under the transcriptional control of the mouse aGSU gene (Cga). A sequence of 4.6 kb of the mouse aGSU gene promoter and enhancer (B6;SJLTg(Cga-cre) 3Sac /J) targets the gonadotropes and thyrotropes, as well as the other hormone-producing cells of the adult anterior pituitary gland (Cushman et al., 2000) . These sequences are sufficient to confer developmentally regulated and hormone-responsive gene expression in the pituitary gland, and they have been used successfully to create pituitary-specific deletions of several genes (Bliss et al., 2009; Charles et al., 2006; Cushman et al., 2000; Kendall et al., 1994) . Ectopic cre activity, however, is observed in the ovary and in the skeletal and cardiac muscle of 4.6 kb aGSU transgenic mice, limiting the usefulness of this transgene for some purposes (Uhlenhaut et al., 2009) .
To generate aGSU-Cre transgenic mice that more accurately recapitulate endogenous aGSU gene expression, we used homologous recombination in E. coli to introduce improved cre recombinase (iCre) coding sequences into a bacterial artificial chromosome (BAC) containing the mouse aGSU gene. A transgenic line carrying this construct conferred highly penetrant cre mediated excision of floxed reporter genes and had minimal ectopic expression. This suggests that regulatory DNA sequences present in the BAC confer more accurate aGSU gene expression than promoterproximal sequences alone.
RESULTS AND DISCUSSION
Cga, a single gene in the mouse genome, encodes aGSU, and is flanked by Zfp292 and Mobkl2b on mouse chromosome 4. Using recombineering in E. coli, we inserted an improved cre expression cassette (iCre) into a 228 kb mouse aGSU genomic BAC clone in exon 1 at the translation start site (Fig. 1) . The iCre has reduced CpG content relative to the prokaryotic coding sequence, thereby reducing the chances of epigenetic silencing in mammals (Shimshek et al., 2002) . The engineered BAC was injected into the pronucleus of fertilized eggs from a C57BL/6J cross with B6D2F1 mice to generate aGSU-iCre BAC transgenic mice. We identified a founder transgenic mouse containing the complete BAC using polymerase chain reaction (PCR) genotyping with primers for the iCre insertion and the BAC vector backbone. This line Tg(Cga-iCre)
Sac961 is referred to here as aGSU-iCre for simplicity.
We determined that the transgene does not affect the expression levels of endogenous aGSU using quantitative PCR (data not shown). To asses the specificity, efficiency, and in vivo activity of the aGSU-iCre BAC transgene, transgenic mice were crossed with two different crereporter transgenic mice that express a reporter gene only after excision of a floxed stop sequence: Rosa 26-LacZ and Rosa26-EYFP (officially B6;129S4-Gt(ROSA) 26Sor . The exon-intron structure of the aGSU gene is shown. The first exon is noncoding (light blue) and four exons are coding (blue rectangles). The recombination targeted the second aGSU exon, inserting the iCre coding sequence at the ATG of the aGSU gene and using the aGSU gene polyadenylation sequence. The 4.6 kb promoter used for the previous aGSU-Cre transgenic mouse is indicated.
respectively). Both aGSU-iCre female and male mice were fertile.
The DNA recombination pattern in the developing pituitary and adult tissues was analyzed by crossing aGSU-iCre mice with the Rosa26-LacZ cre reporter line (Friedrich and Soriano, 1991; Soriano, 1999; Zambrowicz et al., 1997) . In transgenic animals carrying both Rosa26-LacZ and aGSU-iCre transgenes, the Cre recombinase catalyzed the removal of the stop sequence, leading to b-galactosidase production. X-Gal stained aGSUiCre;Rosa26LacZ double transgenic embryos showed that recombination occurred in the developing pituitary gland at embryonic day 11.5 (e11.5), in a few cells (data not shown). This is consistent with the developmental timing of endogenous aGSU expression (Kendall et al., 1991) . By e12.5 essentially all of the cells at the ventral aspect of the pouch are stained, with a pattern of expression characteristic of endogenous aGSU expression (Fig. 2) . Little or no staining was detected in the bodies of whole mount stained embryos, while the 4.6 kb aGSU-cre transgene was active in the somites at e12.5 and other ectopic sites (Cushman et al., 2000) . After removing the mandible, transgene activity is obvious in the developing pituitary gland and in other areas that express endogenous aGSU: the mesenchyme adjacent to the eye and the olfactory epithelium (Kendall et al., 1991) . Sagittal sections revealed X-gal staining confined to the expected rostral, ventral area of Rathke's pouch where differentiated cells expressing aGSU are appearing. At e11.5 limited b-galactosidase activity was detected (data not shown) (Cushman et al., 2000) . This is consistent with the developmental timing of endogenous aGSU expression (Kendall et al., 1991) . These results show that the new aGSU-iCre BAC transgenic mouse line mediates recombination much more specifically than the previous line using only 4.6 kb of regulatory sequences.
The tissue specificity of the aGSU-iCre transgene was analyzed by X-Gal staining of cryosections from adult tissues (2 mo old) from aGSU-iCre; Rosa26LacZ double transgenic mice. Cre transgene activity was detected in the pituitary of 2 mo old adult mice, with no activity in inappropriate tissues such as muscle, kidney, lung, testis, and liver (Fig. 3 ). A few rare, positive cells were detected in the brain, and low levels of activity were noted in some follicles of the ovary (Fig. 3) . Because of the potential for multiple organs in the hypothalamicpituitary-gonadal axis to be affected in gene deletion studies using the aGSU-icre, we characterized Cre expression in the ovary using a different reporter mouse, Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J, which switches from red fluorescent tdTomato to green fluorescent eGFP upon recombination. Only a few scattered cells in some, but not all ovaries, were detected using either reporter mouse. Although this may affect the results of gene deletion, if the gene of interest is expressed in the ovary, the aGSU-iCre BAC transgenic line greatly improves pituitary specificity over previously available reagents and more accurately reflects the expression of the endogenous aGSU gene.
To study the pituitary cell specificity, the aGSU-iCre transgenic mice were crossed with Rosa26-EYFP cre reporter line. In this reporter mouse line, cre excision of the loxP-flanked STOP fragment permits EYFP gene expression (Madisen et al., 2010) that can be detected by antibody staining against EGFP. Cell specificity was assessed by following EGFP immunohistochemistry (IHC) with staining for individual antibodies specific to each of the pituitary hormones (aGSU, TSHb, LHb, FSHb, GH, PRL, and ACTH). IHC on pituitary cryosections from aGSU-iCre; Rosa26EYFP double transgenic mice reveals high levels of aGSU-iCre activity in the anterior lobe of the pituitary, with no expression in the intermediate and posterior lobe (Fig. 4A) . Double IHC for eGFP and aGSU reveals that most aGSU positive cells undergo cre recombination (Fig. 4B) . Quantitation of hormone positive cells for EGFP expression revealed a high level of penetrance in gonadotropes and thyrotropes with a low level of expression in other pituitary cell types (Fig. 5, Table 1 ). About 79% of aGSU producing cells are marked and most thyrotropes and gonadotropes were marked. EYFP IHC was detected in cells positive for TSHb (96%), LHb (67%) and FSHb (91%).
Less than 10% of cells positive for other hormones express EYFP: ACTH (8%), GH (6%) or PRL (7%). This may not represent ectopic expression because aGSU is detectable in a variety of pituitary cell types (Childs, 1991; Saeger et al., 2007; Seuntjens et al., 2002) .
In summary, we have generated an improved aGSUiCre transgenic mouse using BAC recombineering. Compared to the original aGSU-cre transgenic mouse, the new line mediates recombination in the pituitary   FIG. 3 . Tg(aGSU-iCre) transgene is active primarily in the pituitary gland. Analysis of cre activity in adult tissues was examined by X-Gal staining of aGSU-iCre;Rosa26LacZ double transgenic mice. Cryo sections were counterstained with neutral red. For the ovary, Tg(aGSUiCre) mice were crossed with the double-fluorescent cre reporter mTmG line, that expresses membrane targeted tandem dimer tomato (mT) prior to cre mediated excision and membrane targeted green fluorescent protein (mG) after excision (Muzumdar et al., 2007) . Ovary sections were counterstained with DAPI (blue). All magnification bars represent 100 mm.
thyrotropes and gonadotropes, without broad expression in other pituitary cell types and without ectopic recombination in the heart, skeletal muscle, and other ectopic sites characteristic of the original line. It is tempting to speculate that the evolutionarily conserved noncoding sequence located 3' of the aGSU gene could have a role in generating appropriate tissue specific, developmentally regulated and cell specific expression, similar to 3' regulatory elements that have been identified for many genes (Antoniou et al., 1988) . BAC recombineered transgenes can be an effective and efficient approach to developing cre strains because identification of all the regulatory elements for accurate gene expression can be tedious, and because knock-in alleles can create haploinsufficiency for the endogenous gene and influence the phenotype.
METHODS

BAC Transgene Construction
BAC clone RP24-329P6 containing mouse Cga was obtained from the BACPAC Resource Center (Oakland, California). The iCre clone was a kind gift of R. Sprengel (Shimshek et al., 2002) . To place iCre under the control of Cga, the loxP recombinase site in the pTARBAC1 BAC cloning vector (Zeng et al., 2001) was replaced with an amp resistance cassette from the pTAMP plasmid as 
FIG. 5.
Tg(aGSU-iCre) is specific for thyrotropes and gonadotropes. Adult pituitary cryo sections from mice doubly transgenic for Tg(aGSU-iCre) and Rosa26EYFP reporter strain were stained by double immunohistochemistry with antibodies against EYFP (green) and each pituitary hormone (red). EYFP expression colocalizes with LHb, FSHb, and TSHb in pituitaries from aGSU-iCre; Rosa26-EYFP double transgenic mice; and not with ACTH, PRL, and GH. Cell nuclei were stained with DAPI (blue).
described (Lee et al., 2001) . A plasmid with an R6K origin of replication containing iCre (nucleotides 1-1056) and an FRT-gb2-kan-FRT cassette was assembled in Pir1 bacteria. To introduce iCre, a 100 bp oligonucleotide was synthesized with 20 bp of homology to the iCre cassette and 80 bp homology immediately downstream of Cga exon 2 (ENSMUSE00000177972) nucleotide 97. This primer replaced the Cga initiator methionine with the initiator methionine of iCre. A second 100 bp oligo was synthesized that contained 80 bp homology that began with intron 2 nucleotide 10 and 20 bp of homology with the iCre cassette. The oligos were used to PCR amplify the iCre-FRT-gb2-kan-FRT cassette from the donor plasmid. The PCR product was used to introduce the iCre-FRT-gb2-kan-FRT cassette into Cga exon 2 of the BAC as described above. FLPe was used to excise the FRT flanked drug selection cassette from the BAC (Lee et al., 2001) . Recombineered BACs were identified by pulsed field restriction enzyme mapping as described (Van Keuren et al., 2009) . The critical region of the BAC was completely sequenced after PCR amplifying the Cga exon 2 iCre knock-in region. Primers used to amplify the iCre-FRT-gb2-kan-FRT cassette were: Primer 1, which aligns to vector backbone and Cga: 5 0 TGAAAGACGGTA GAAAGGAACTAA TCATTATTGATG TGCATCTAGAAA CTTGTTTCCCTT TTCATGGCAAGC CTGAGCTTATAT ACGAAGTTATAA GCTT 3 0 and Primer 2, which aligns to iCre and Cga: 5 0 ACAGCTGGCTTG GGTTATGACTGG TAAGCTAAGATT ACACTGTTATTA TTTTTTTTTTCA TGTGCAGCTTGC AGAAGAGCTATG GTGCCCAAGAAG AAGA 3 0 , with a product size of 2330 bp.
Generation and Genotyping of Transgenic Mice
All experiments using mice were approved by the University of Michigan Committee on Use and Care of Animals. The engineered BAC (aGSU-iCre) was injected into the pronuclei of fertilized eggs from a C57BL/6J cross with B6D2F1 mice and the fertilized eggs were transferred into pseudopregnant foster mothers. Transgene positive progeny were genotyped using PCR amplification of genomic DNA with primers that flank the junction of the aGSU promoter and the inserted iCre coding sequence: 5 0 -TGAAGCCATCTCTCTGAGC AA-3 0 and 5 0 -CACAGTCAGCAGGTTGGAGA-3 0 , under the following conditions: 92 C for 2 min, followed by 30 cycles of 92 C for 10 s, 57 C for 30 s and 72 C for 30 s, and a final 10 min extension at 72 C. Transgene positive progeny were also genotyped using primers specific for the chloramphenicol resistance gene located in the BAC backbone to identify mice that harbor the complete BAC: 5 0 -TCACTACCGGGCGTATTTTT-3 0 and 5 0 -GCCGGATAAAACTTGTGCTT-3 0 and the same PCR cycling conditions. B6;129S4-Gt(ROSA)26Sor tm1Sor /J, B6.Cg-Gt(ROSA)26 Sor tm2(CAG-EYFP)Hze /J, and Gt(ROSA)26Sor tm4(ACTB-td Tomato,-EGFP)Luo /J reporter mice are all available from The Jackson Laboratory, and were maintained as homozygotes.
In all the experiments, animals carried one allele of the cre transgene and one allele of the reporter gene, whereas controls were negative for the cre transgene but positive for a reporter gene.
Histology and Immunohistochemistry
Adult tissues and embryos were collected and fixed for 1 h in 4% formaldehyde in PBS. For embryos, noon of the day of the vaginal plug is designated as embryonic day 0.5. X-gal staining was performed as previously described (Brinkmeier et al., 1998) . After staining, embryos and adult organs were embedded in OCT (Sakura Finetek Co., Torrance, CA), and cryosectioned at 16 mm thickness. Cryosections were counterstained for 2 min with 1% neutral red stain plus 4% sodium acetate: glacial acetic acid. Sections were mounted with xylene:permount 1:2 (Fisher) mounting media.
Immunohistochemistry for GFP and hormones was performed on 16 mm pituitary cryosections. Frozen pituitary sections were fixed for 5 min in 4% formaldehyde and rinsed in 13 PBS. Immunostaining was performed using a goat polyclonal anti-GFP (Abcam) antibody overnight at 4 C, diluted 1:1000 in a blocking solution comprised of 3% normal donkey serum, 1% BSA, and 0.5% Triton-X100 in 13 PBS. Slides were washed three times for 5 min in 13 PBS, followed by 1 h incubation with biotinylated anti-goat secondary antibody (Jackson Immunoresearch). Streptavidin-Alexa 488 (Invitrogen) was added for 1 h at 1:100 dilution in 13 PBS. Immunostaining for the different hormones was carried out with antibodies against each of the pituitary hormones: rabbit anti-aGSU (1:50), guinea pig anti-LHb (1:100), rabbit anti-FSHb (1:50), rabbit antiTSHb (1:200), rabbit anti recombinant PRL (1:200), monkey anti-GH (1:500), and rabbit anti-ACTH (1:150) (National Hormone and Pituitary Program, NIDKK). c Different from #, P < 0.05.
Secondary detection was performed as described above using biotinylated anti-rabbit or anti-guinea antibody (Vector Laboratories) and streptavidin-Cy3 (Jackson Immunoresearch), then washed in PBS and mounted with fluorescent mounting media and images were captured using a Retiga 2000R camera mounted on a Leica DMRB fluorescent microscope.
The aGSU-iCre mice will be available upon request. We recommend using them as hemizygotes since we evaluated a total of 45 mice borne from a cross of two hemizygous carriers, and none of them were homozygous; suggesting that homozygosity for the transgene is lethal.
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